Novel 18F And 64Cu Labelled Targeted Nanoparticles For Molecular Positron Emission Tomography: A Means For Early And Sensitive Detection Of Thrombosis, Inflammation And Vulnerable, Rupture-prone Atherosclerotic Plaques
Funder
National Health and Medical Research Council
Funding Amount
$572,931.00
Summary
The aim of this project is to develop novel targeted positron emission tomography imaging agents that seek out specific markers for various states of cardiovascular disease. These agents would provide a method for detecting the presence and level of atherosclerosis and thrombotic events. The targeted nanoparticles may provide a unique opportunity to detect very early plaques and the vulnerability of existing plaques.